Concepedia
Statistics
Publications
12
Citations
667
H-Index
10
Active since
1989
Affiliations
Pfizer (United States)(Current)
Monsanto (United States)
Pfizer (United Kingdom)
John M. Molyneaux is an author at Pfizer (United States) specializing in drug discovery, pharmacy, and pharmacology.
Publications per year
1989–2011
Structure of a bacterial quorum-sensing transcription factor complexed with pheromone and DNA
Rongguang Zhang, Katherine M. Pappas, Jennifer L. Brace et al. · Nature · 2002 · 441 citations
Life Sciences, Microbiology, Molecular Biology +11
Design of potent inhibitors of human β-secretase. Part 2
John N. Freskos, Yvette M. Fobian, Timothy E. Benson et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 39 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +13
Design of potent inhibitors of human β-secretase. Part 1
John N. Freskos, Yvette M. Fobian, Timothy E. Benson et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 32 citations
A novel dehydrofluorination of 2-(trifluoromethyl)dihydro-3,5-pyridinedicarboxylates to 2-(difluoromethyl)-3,5-pyridinedicarboxylates
Len F. Lee, Gina L. Stikes, John M. Molyneaux et al. · The Journal of Organic Chemistry · 1990 · 29 citations
Natural Sciences, Chemistry, Drug Discovery +4
Identification, synthesis and SAR of amino substituted pyrido[3,2b]pyrazinones as potent and selective PDE5 inhibitors
Dafydd R. Owen, John K. Walker, E. Jon Jacobsen et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 23 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +12
1–5 of 12